These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1158 related articles for article (PubMed ID: 2777216)

  • 1. Basement membrane deposition in benign and malignant naevo-melanocytic lesions: an immunohistochemical study with antibodies to type IV collagen and laminin.
    Havenith MG; van Zandvoort EH; Cleutjens JP; Bosman FT
    Histopathology; 1989 Aug; 15(2):137-46. PubMed ID: 2777216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of basement membranes in pigment cell tumors of the skin, relation to cell type and clinical behavior.
    Stenbäck F; Wasenius VM
    J Cutan Pathol; 1986 Jun; 13(3):175-86. PubMed ID: 3525624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanocytes in nevi and melanomas synthesize basement membrane and basement membrane-like material. An immunohistochemical and electron microscopic study including immunoelectron microscopy.
    Schaumburg-Lever G; Lever I; Fehrenbacher B; Möller H; Bischof B; Kaiserling E; Garbe C; Rassner G
    J Cutan Pathol; 2000 Feb; 27(2):67-75. PubMed ID: 10678701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of laminin and collagen type-IV in benign and malignant lesions of melanocytic origin.
    Natali PG; Nicotra MR; Bellocci M; Cavaliere R; Bigotti A
    Int J Cancer; 1985 Apr; 35(4):461-7. PubMed ID: 3886560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of basement membrane components in eosinophilic globules in a case of Spitz's nevus.
    Schmoeckel C; Stolz W; Burgeson R; Krieg T
    Am J Dermatopathol; 1990 Jun; 12(3):272-4. PubMed ID: 1693820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of basement membranes in malignant melanoma and nevocytic nevi.
    Schmoeckel C; Stolz W; Sakai LY; Burgeson RE; Timpl R; Krieg T
    J Invest Dermatol; 1989 May; 92(5):663-8. PubMed ID: 2497191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical investigation of alpha1 (IV) and alpha5 (IV) collagen chains in a broad spectrum of melanocytic tumours.
    Quatresooz P; Piérard GE
    Melanoma Res; 2005 Jun; 15(3):161-8. PubMed ID: 15917697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear pseudoinclusions in melanocytic naevi and melanomas.
    Rose DS
    J Clin Pathol; 1995 Jul; 48(7):676-7. PubMed ID: 7560180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical studies comparing the localization of type XV collagen in normal human skin and skin tumors with that of type IV collagen.
    Fukushige T; Kanekura T; Ohuchi E; Shinya T; Kanzaki T
    J Dermatol; 2005 Feb; 32(2):74-83. PubMed ID: 15906535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extracellular matrix in pigmented skin lesions: an immunohistochemical study.
    Van Duinen CM; Fleuren GJ; Bruijn JA
    Histopathology; 1994 Jan; 24(1):33-40. PubMed ID: 7511560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IV collagen and laminin staining patterns in benign and malignant cutaneous lesions.
    Mackie RM; Clelland DB; Skerrow CJ
    J Clin Pathol; 1989 Nov; 42(11):1173-7. PubMed ID: 2479664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR; El-Zammar O
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of basement membrane antigens in spindle cell melanoma.
    Prieto VG; Woodruff JM
    J Cutan Pathol; 1998 Jul; 25(6):297-300. PubMed ID: 9694618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
    Pisacane AM; Risio M
    Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
    Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of two morphologic parameters concerning tumor-stroma interaction in benign and malignant melanocytic skin lesions.
    Fink-Puches R; Smolle J; Hofmann-Wellenhof R; Kerl H
    Am J Dermatopathol; 1998 Oct; 20(5):468-72. PubMed ID: 9790107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ analysis of transforming growth factor-beta s (TGF-beta 1, TGF-beta 2, TGF-beta 3), and TGF-beta type II receptor expression in malignant melanoma.
    Schmid P; Itin P; Rufli T
    Carcinogenesis; 1995 Jul; 16(7):1499-503. PubMed ID: 7614683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basement membrane in Kaposi's sarcoma: an immunohistochemical and ultrastructural study.
    Bendelac A; Kanitakis J; Chouvet B; Thivolet J
    Pathol Res Pract; 1985 Dec; 180(6):626-32. PubMed ID: 3913949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endoglin in human melanocytic lesions.
    Dawn G; MacKie RM
    Clin Exp Dermatol; 2002 Mar; 27(2):153-6. PubMed ID: 11952710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.